1-6 of 6
David Weinstock, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Newer-Generation HSP90 Inhibitors Can Overcome Ibrutinib Resistance and Suppress Proliferation in Human Mantle Cell Lymphoma in Vitro and in Vivo

Nadja Kopp, MA, Sebastian Tschuri, Sarah Haebe, Diederik van Bodegom, PhD, Liat Bird, Amanda L. Christie, Amy Saur, Alexandra N. Christodoulou, Trevor Tivey, Andrew L Kung, MD PhD, Oliver Weigert, MD, David Weinstock, MD
Journal: Blood
Blood (2014) 124 (21): 1686.
https://doi.org/10.1182/blood.V124.21.1686.1686
Published: 2014
Journal Articles

JAK2 L884P Mutation Confers Resistance To The Type II JAK2 Inhibitor NVP-BBT594 When Co-Occurring With JAK2 R683G But Not JAK2 V617F

Nadja Kopp, Jordy C. Van der Zwet, Jacob Layer, Oliver Weigert, Eric Vangrevelinghe, Akinori Yoda, PhD, Thomas Radimerski, PhD, David Weinstock, MD
Journal: Blood
Blood (2013) 122 (21): 1429.
https://doi.org/10.1182/blood.V122.21.1429.1429
Published: 2013
Journal Articles

A Targeted Mutational Landscape of Angioimmunoblastic T-Cell Lymphoma: Association Between Advanced Age and Mutations in TET2 and DNMT3A

Oliver Weigert, MD, Nadja Kopp, Sudha Bolla, MD, Oreofe Odejide, MD, Dan Toscano, Matthew A Lunning, DO, Julie Teruya-Feldstein, MD, Abner Louissaint, MD, PhD, Scott J. Rodig, MD, PhD, Steven M. Horwitz, MD, David Weinstock, MD
Journal: Blood
Blood (2012) 120 (21): 299.
https://doi.org/10.1182/blood.V120.21.299.299
Published: 2012
Journal Articles

Newer-Generation HSP90 Inhibitors Have Potent Activity Against Human Mantle Cell Lymphoma in Vitro and in Vivo

Oliver Weigert, MD, Diederik van Bodegom, PhD, Liat Bird, Amy Saur, Trevor Tivey, Nadja Kopp, Andrew L. Kung, MD, PhD, David Weinstock, MD
Journal: Blood
Blood (2012) 120 (21): 1651.
https://doi.org/10.1182/blood.V120.21.1651.1651
Published: 2012
Journal Articles

Trisomy of the Down Syndrome Critical Region Suppresses Precursor B-Cell Differentiation and Promotes B-Cell Transformation Associated with Altered Expression of Polycomb Repressor Complex 2 Targets

Andrew A. Lane, MD, PhD, Diederik van Bodegom, PhD, Bjoern Chapuy, MD, PhD, Gabriela Alexe, PhD, Timothy J Sullivan, PhD, Trevor Tivey, Tovah Day, PhD, John Crispino, PhD, Edward Fox, PhD, Kimberly Stegmaier, MD, David Weinstock, MD
Journal: Blood
Blood (2012) 120 (21): 115.
https://doi.org/10.1182/blood.V120.21.115.115
Published: 2012
Journal Articles

BET Bromodomain Inhibition Targets Both c-Myc and IL7R in Acute Lymphoblastic Leukemia

Nadja Kopp, Christopher J. Ott, PhD, Liat Bird, Ronald Paranal, Jun Qi, PhD, Teresa Bowman, Scott J. Rodig, MD, PhD, Andrew L. Kung, MD, PhD, James E. Bradner, MD, David Weinstock, MD
Journal: Blood
Blood (2012) 120 (21): 672.
https://doi.org/10.1182/blood.V120.21.672.672
Published: 2012